Development of intravenous drug ganaxolone
Ended Definitive Contract Awarded Last action
- Contract number
- 75A50120C00159
- Awardee
-
Immedica Pharma US Inc. UEI MS6UM2NBDW91
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $33,656,933
Award facts
- Opportunity
-
- R&D to develop Ganaxolone to treat status epilepticus Award Notice · Posted Sep 14, 2020
- Contract value 100% obligated
- $33,656,933.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Cost Sharing
- Place of performance
- Wayne, PA 19087, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $12,318,053 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $21,338,880 |
About this award
The Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response has awarded a $33,656,933.00 cost-sharing contract to Marinus Pharmaceuticals, Inc. to support the development of the intravenous drug ganaxolone. This definitive, six-year contract does not have a set-aside designation. Ganaxolone is a drug being developed by Marinus Pharmaceuticals that could aid in the treatment of seizure disorders and has implications for emergency response. In addition to this prime contract, Marinus Pharmaceuticals holds two Federal Supply Schedule contracts with the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 to facilitate the delivery of pharmaceutical products, including ganaxolone, to VA medical centers nationwide.
Quick answers
Who was awarded contract 75A50120C00159?
75A50120C00159 was awarded to Immedica Pharma US Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 8, 2020.
How much is contract 75A50120C00159 worth?
The government has obligated $33,656,933 on 75A50120C00159.
Was contract 75A50120C00159 competed?
The extent of competition for 75A50120C00159 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award